Abstract

Genomic studies of patients with COVID-19, or exposed to it, are underway to delineate host factors associated with variability in susceptibility, infectivity, and disease severity. Here, we highlight the ethical implications—both potential benefits and harms—of genomics for clinical practice and public health in the era of COVID-19.

Details

Title
Genomics in the era of COVID-19: ethical implications for clinical practice and public health
Author
Geller, Gail  VIAFID ORCID Logo  ; Duggal, Priya; Thio, Chloe L; Mathews, Debra; Kahn, Jeffrey P; Maragakis, Lisa L; Garibaldi, Brian T
Pages
1-4
Section
Comment
Publication year
2020
Publication date
2020
Publisher
BioMed Central
e-ISSN
1756994X
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1186/s13073-020-00792-9
ProQuest document ID
2462184956
Copyright
© 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.